Amanda Moukdad
Internal Medicine · Secaucus, NJNPI 1326605528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,139 and has fallen 97.6% since, to $51 in 2025.
Across 164 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$667
- AbbVie$458
- Boehringer Ingelheim$325
- Corcept Therapeutics$315
- Novo Nordisk$273
- Intra-sana Laboratories$263
- plus $1K from 26 others
What the payments were for
- Food & beverage$3,785100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 19 | $667 |
| AbbVie | 16 | $458 |
| Boehringer Ingelheim | 7 | $325 |
| Corcept Therapeutics | 18 | $315 |
| Novo Nordisk | 19 | $273 |
| Intra-sana Laboratories | 5 | $263 |
| Johnson & Johnson | 10 | $232 |
| Inari Medical, Inc. | 1 | $133 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $122 |
| Axsome Therapeutics, Inc. | 6 | $95 |
| AstraZeneca | 6 | $92 |
| Lilly USA, LLC | 6 | $85 |
| Tolmar, Inc. | 5 | $77 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| Bayer | 3 | $67 |
| Almatica Pharma LLC | 4 | $62 |
| Exact Sciences | 3 | $49 |
| Amgen(2 entities) | 3 | $49 |
| Idorsia Pharmaceuticals US Inc | 3 | $42 |
| Aurinia Pharma U.S., Inc. | 1 | $35 |
| Lundbeck LLC | 2 | $32 |
| Recordati_rare_diseases_inc. | 2 | $30 |
| Edwards Lifesciences | 1 | $21 |
| Philips North America LLC | 1 | $18 |
| Novartis | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$250
- JARDIANCE$244
- FLOWTRIEVER CATHETER, S$133
- CT THROMBECTOMY SYSTEM KIT$133
- Reltone 200 Mg$132
- GLYCATE$132
- Reltone 400 Mg$132
- SPRAVATO$127
- VRAYLAR$125
- QULIPTA$125
How this compares
$3,785 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alprazolam | 15 | $71 |
| Amlodipine Besylate | 14 | $70 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Secaucus
- Angel LazoSecaucus$195K
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.